HRT Financial LP (SHPH) discloses 60,540 common shares as ten percent owner

Rhea-AI Filing Summary

HRT Financial LP filed an initial ownership report as a ten percent owner of Shuttle Pharmaceuticals Holdings, Inc. (SHPH). The filing lists direct beneficial ownership of 60,540 shares of Common Stock as of the reported date, without reporting any specific buy or sell transaction.

Filing Explained

As of July 9, Adam Nunes disclosed direct ownership of 60,540 common shares, with no derivative securities listed.

The July 13, 2026 Form 3 is an initial beneficial-ownership statement with a July 9, 2026 event date; it records the reporting person's direct common-stock holding.

It identifies Adam Nunes as a 10% owner and reports 60,540 shares of common stock held directly.

No derivative securities are listed in Table II, so the disclosed position is direct common-stock ownership rather than a reported exercise or conversion position.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider HRT FINANCIAL LP

Role 10% Owner

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 60,540 shares (Direct)

Footnotes (1)

Key Figures

Common Stock Held: 60,540 shares Holding Entries: 1 Unknown Transaction Entries: 1

3 metrics

Common Stock Held 60,540 shares Direct beneficial ownership reported by HRT Financial LP as of the Form 3 date

Holding Entries 1 Number of holding entries reported in the non-derivative transaction summary

Unknown Transaction Entries 1 Transaction summary shows one entry categorized with an unknown transaction code

Key Terms

ten percent owner, Common Stock, direct beneficial ownership

3 terms

ten percent owner regulatory

"The filing identifies HRT Financial LP as a ten percent owner of SHPH."

Common Stock financial

"The report lists direct beneficial ownership of 60,540 shares of Common Stock."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

direct beneficial ownership financial

"The Form 3 reports direct beneficial ownership of 60,540 shares."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 07/13/2026 - 02:22 PM Accepted by SEC EDGAR 07/13/2026 - 02:21 PM Learn about SEC filing dates

FAQ

What does the SHPH Form 3 filed by HRT Financial LP report?

The Form 3 reports that HRT Financial LP, a ten percent owner of SHPH, holds 60,540 shares of Common Stock directly. It is an initial ownership statement and does not detail any specific purchase or sale transactions.

How many Shuttle Pharmaceuticals (SHPH) shares does HRT Financial LP report owning?

HRT Financial LP reports direct beneficial ownership of 60,540 shares of SHPH Common Stock. This amount reflects its reported holding after the referenced date, serving as a baseline position for future insider ownership updates.

Is HRT Financial LP a ten percent owner of Shuttle Pharmaceuticals (SHPH)?

Yes. The filing identifies HRT Financial LP as a ten percent owner of Shuttle Pharmaceuticals Holdings, Inc. This status generally indicates significant ownership and requires public reporting of holdings and subsequent changes.

Does the SHPH Form 3 show any recent insider buying or selling by HRT Financial LP?

No specific buy or sell transactions are shown. The Form 3 functions as an initial ownership statement, listing a direct holding of 60,540 shares of SHPH Common Stock without identifying transaction dates or prices for acquisitions or dispositions.

What type of security does HRT Financial LP hold in Shuttle Pharmaceuticals (SHPH)?

HRT Financial LP holds Common Stock of Shuttle Pharmaceuticals Holdings, Inc. The Form 3 reports a direct position of 60,540 common shares, with no derivative securities listed in the derivative holdings summary.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

HRT FINANCIAL LP

(Last) (First) (Middle)

3 WORLD TRADE CENTER, 175 GREENWICH STRE

76TH FLOOR

(Street)

NEW YORK NEW YORK 10007

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/09/2026

3. Issuer Name and Ticker or Trading Symbol
Shuttle Pharmaceuticals Holdings, Inc. [ SHPH ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	60,540	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Adam Nunes	07/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)